Search

Your search keyword '"Lachmann B"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Lachmann B" Remove constraint Author: "Lachmann B" Topic respiratory distress syndrome Remove constraint Topic: respiratory distress syndrome
76 results on '"Lachmann B"'

Search Results

1. Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS).

2. Experimental blunt chest trauma--cardiorespiratory effects of different mechanical ventilation strategies with high positive end-expiratory pressure: a randomized controlled study.

3. Automatic protective ventilation using the ARDSNet protocol with the additional monitoring of electrical impedance tomography.

4. Acute respiratory failure complicating advanced liver disease.

5. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.

6. Additives in intravenous anesthesia modulate pulmonary inflammation in a model of LPS-induced respiratory distress.

7. Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model.

8. The open lung concept of mechanical ventilation: the role of recruitment and stabilization.

9. Lung protective ventilatory strategies in acute lung injury and acute respiratory distress syndrome: from experimental findings to clinical application.

10. Lung protective ventilation in ARDS: the open lung maneuver.

11. Contrast media inhibit exogenous surfactant therapy in rats with acute respiratory distress syndrome.

12. Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery.

13. Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation.

14. Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model.

15. Surfactant therapy for acute lung injury/acute respiratory distress syndrome.

16. Phosphoinositide 3-OH kinase inhibition prevents ventilation-induced lung cell activation.

17. Open lung in ARDS.

18. Injurious ventilation strategies cause systemic release of IL-6 and MIP-2 in rats in vivo.

19. Ventilator-induced heat shock protein 70 and cytokine mRNA expression in a model of lipopolysaccharide-induced lung inflammation.

20. Lung protective ventilation in ARDS: role of mediators, PEEP and surfactant.

21. Open Lung in ARDS.

22. [Experimental results of using the "open lung concept"].

23. The open lung concept of alveolar recruitment can improve outcome in respiratory failure and ARDS.

24. Treatment of ventilation-induced lung injury with exogenous surfactant.

25. Monitoring of recruitment and derecruitment by electrical impedance tomography in a model of acute lung injury.

26. Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure.

27. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha.

28. At surfactant deficiency, application of "the open lung concept" prevents protein leakage and attenuates changes in lung mechanics.

29. Regional pressure volume curves by electrical impedance tomography in a model of acute lung injury.

30. Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury.

31. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation in a model of acute lung injury.

32. Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).

33. [An automated concept for optimal ventilation of ARDS patients].

34. Mechanisms of acute respiratory distress syndrome: role of surfactant changes and mechanical ventilation.

35. Exogenous surfactant and nitric oxide have a synergistic effect in improving gas exchange in experimental ARDS.

36. Partial liquid ventilation and inhaled nitric oxide have a cumulative effect in improving arterial oxygenation in experimental ARDS.

37. The lung in distress.

38. Effects of volume controlled ventilation with PEEP, pressure regulated volume controlled ventilation and low frequency positive pressure ventilation with extracorporeal carbon dioxide removal on total static lung compliance and oxygenation in pigs with ARDS.

39. Hemodynamic effects of partial liquid ventilation with perfluorocarbon in acute lung injury.

40. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS).

41. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).

42. Respiratory and haemodynamic effects of conventional volume controlled PEEP ventilation, pressure regulated volume controlled ventilation and low frequency positive pressure ventilation with extracorporeal carbon dioxide removal in pigs with acute ARDS.

43. Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose-dependent improvement of gas exchange.

44. Evaluation of oxygenation with different modes of ventilation in patients with adult respiratory distress syndrome.

45. Acute respiratory failure during pneumonia induced by Sendai virus.

46. Comparison of different modes of artificial ventilation with extracorporeal CO2 elimination on gas exchange in an animal model of acute respiratory failure.

47. Gas exchange and lung mechanics during long-term mechanical ventilation with intratracheal perfluorocarbon administration in respiratory distress syndrome.

48. Dose-dependent improvement of gas exchange by intratracheal perflubron (perfluorooctylbromide) instillation in adult animals with acute respiratory failure.

49. Oxygen uptake in the lungs under pathological conditions and its therapeutic efforts.

50. Comparison of pressure support ventilation (PSV) and intermittent mandatory ventilation (IMV) during weaning in patients with acute respiratory failure.

Catalog

Books, media, physical & digital resources